1,24,25-Trihydroxyergocalciferol.
Research-backed vitamin with potential health benefits. It's an active metabolite of Vitamin D2, involved in calcium regulation. Your body makes it as needed. It's not meant for direct supplementation.
Reviewed March 2026
- Category
- Vitamin
What 1,24,25-Trihydroxyergocalciferol is, and what it does.
- Does it work
- No. For general health, it's useless. This is for researchers in white lab coats, not for your morning smoothie.
- How much to take
- Zero. Don't take this. Supplement with 2000-5000 IU of regular Vitamin D3 instead and let your body do the conversion.
- Time to feel it
- There's nothing to time here. It's an intermediate the body forms while clearing vitamin D2, and it is read on a laboratory assay rather than experienced.
- The first dose
- Nothing, because you won't be taking it. If you did, who knows? It's not studied for this purpose.
- With regular use
- Unknown and irrelevant for supplementation. The long-term plan is to take regular D3 and maintain healthy levels.
- How well tolerated
- Unknown for supplementation. Messing with active hormone metabolites is a bad idea without medical supervision for a specific condition. Stick to the precursors.
- How it feels
- Like nothing. It's a background metabolic player, not something you feel. The 'feeling' comes from having adequate overall Vitamin D levels, not from taking one specific metabolite.
- The overlooked benefit
- Its existence is the useful part. Rising 24-hydroxylated metabolites are the body's own brake on vitamin D signalling, which is why the pathway is self-limiting.
0.3 to 1mcg a day is where 1,24,25-Trihydroxyergocalciferol works.
Source: Based on parent vitamin D2 metabolite dosing; NIH ODS Vitamin D
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
1,24,25-Trihydroxyergocalciferol is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- vitamin D2 catabolism through the C-24 oxidation pathwayNarrative review
- lower vitamin D receptor affinity than the 1,25-dihydroxy parentIn vitro study
- calcium handling in animal modelsAnimal study
- use as a reference standard in vitamin D metabolite assaysNarrative review
Questions people ask about 1,24,25-Trihydroxyergocalciferol.
- Is this better than regular Vitamin D?
- No. It's an unnecessary, complicated step. Your body is great at converting standard Vitamin D3 into what it needs. Don't overthink it.
- Can I buy this as a supplement?
- You shouldn't be able to. It's a research chemical. If you see it for sale, run the other way.
- Why does it even exist?
- It's a molecule your body makes to fine-tune calcium and phosphate levels. It's part of the complex Vitamin D endocrine system.
- What's the difference between D2 and D3 metabolites?
- This one comes from D2 (ergocalciferol), found in plants. D3 (cholecalciferol) comes from animal sources and sunlight. D3 is generally better for raising blood levels.
- Will this help with bone health?
- Indirectly, as part of the D pathway. But taking it directly is not the way. Proper D3 supplementation is the proven path to supporting bone health.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Hydroxylated ergocalciferol metabolites act through the vitamin D receptor to set the expression of intestinal calcium transport proteins. Calcium is the substrate that machinery moves, so the two are read together rather than separately. The 1,24,25-trihydroxy metabolite carries an extra hydroxyl at C24, which marks it for clearance rather than for sustained receptor signalling. Its place in the pairing is metabolic rather than a dosing recommendation.
Vitamin D metabolites influence intestinal phosphate absorption alongside calcium. Phosphate status in turn feeds back on the renal hydroxylases that produce and clear these metabolites, including the 24-hydroxylase step this compound sits downstream of. The relationship runs in both directions and is regulatory, not additive.
Magnesium is required by enzymes involved in the hydroxylation and transport of vitamin D metabolites. Low magnesium status therefore changes the metabolite pattern a body generates, including the balance between the 1-alpha and the 24-hydroxylated arms. This is a cofactor relationship, described here for the metabolite family rather than as a supplement pairing for this research compound.
Vitamin D receptor transcriptional activity requires heterodimerisation with the retinoid X receptor. Retinoid supply therefore shapes how strongly any vitamin D metabolite signals at a given concentration. Because the C24 hydroxyl weakens receptor affinity in this metabolite, the retinoid contribution is described at the level of the shared receptor complex, not as a potency claim for this molecule.
The vitamin D receptor binds DNA through zinc-coordinated finger motifs, so zinc availability is structural to the whole pathway any D metabolite acts through. This is a general requirement of the receptor rather than an interaction specific to the 1,24,25-trihydroxy species. It is mechanistic biochemistry with no clinical trial behind the pairing.
Ergocalciferol and cholecalciferol metabolites share vitamin D binding protein, the 25- and 1-alpha-hydroxylases and the 24-hydroxylase that produces compounds like this one. The side chain differs between the D2 and D3 series, which changes binding affinity and turnover rate. Presence of one series therefore alters the measured metabolite profile of the other. This is a pharmacokinetic relationship, not an efficacy comparison.
Vitamin D metabolites drive expression of Gla proteins, and vitamin K supplies the cofactor for the carboxylation that makes those proteins functional. The two nutrients sit in sequence on one pathway supporting normal bone mineral handling. This compound belongs to the catabolic branch of the vitamin D series, so the pairing describes the family it comes from.
Nothing specific on file for 1,24,25-Trihydroxyergocalciferol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What 1,24,25-Trihydroxyergocalciferol actually does.
Ergocalciferol is hydroxylated at C25 in the liver and at C1-alpha in the kidney by CYP27B1 to yield the receptor-active metabolite; hydroxylation at C24 by CYP24A1 opens the C-24 oxidation pathway that ends in the water-soluble excretion product calcitroic acid.
A hydroxyl group at C24 lowers affinity for the vitamin D receptor relative to the 1,25-dihydroxy parent, which is why 24-hydroxylated species such as this one are read as catabolic intermediates rather than as signalling ligands.
The D2 side chain carries a C24 methyl group and a C22 to C23 double bond that the D3 side chain lacks, and those differences change how vitamin D binding protein and the hydroxylase enzymes handle the molecule.
Vitamin D metabolites circulate bound to vitamin D binding protein and albumin, so the free fraction available to tissues is set by binding protein concentration rather than by total metabolite alone.
Where 1,24,25-Trihydroxyergocalciferol comes from.
This is a lab-made version of a substance the body produces while breaking vitamin D2 down. It is made in small quantities for research and testing, not for supplement bottles.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Vitamin D2, itself obtained by ultraviolet irradiation of ergosterol from yeast or fungal biomass, is the starting scaffold for the metabolite series.
Hydroxyl groups are introduced at C1, C24 and C25 by multi-step organic synthesis, or in some laboratories by enzymatic hydroxylation using recombinant cytochrome P450 systems.
The target isomer is separated from closely related hydroxylated species by preparative chromatography, since side-chain and ring hydroxylation generate several near-identical products.
Identity and purity are confirmed by mass spectrometry and nuclear magnetic resonance against a reference standard, the usual practice for a research-grade metabolite.
Supplied in milligram or microgram quantities as an analytical standard, typically in solvent, for use in assay work rather than in consumer formulation.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.